192 related articles for article (PubMed ID: 23480182)
1. Controlling immune response and demyelination using highly potent bifunctional peptide inhibitors in the suppression of experimental autoimmune encephalomyelitis.
Kiptoo P; Büyüktimkin B; Badawi AH; Stewart J; Ridwan R; Siahaan TJ
Clin Exp Immunol; 2013 Apr; 172(1):23-36. PubMed ID: 23480182
[TBL] [Abstract][Full Text] [Related]
2. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
Kobayashi N; Kobayashi H; Gu L; Malefyt T; Siahaan TJ
J Pharmacol Exp Ther; 2007 Aug; 322(2):879-86. PubMed ID: 17522343
[TBL] [Abstract][Full Text] [Related]
3. Antigen-specific suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor: structure optimization and pharmacokinetics.
Ridwan R; Kiptoo P; Kobayashi N; Weir S; Hughes M; Williams T; Soegianto R; Siahaan TJ
J Pharmacol Exp Ther; 2010 Mar; 332(3):1136-45. PubMed ID: 20026673
[TBL] [Abstract][Full Text] [Related]
4. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire.
Kuchroo VK; Anderson AC; Waldner H; Munder M; Bettelli E; Nicholson LB
Annu Rev Immunol; 2002; 20():101-23. PubMed ID: 11861599
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic and therapeutic suppression of experimental autoimmune encephalomyelitis by a novel bifunctional peptide inhibitor.
Kobayashi N; Kiptoo P; Kobayashi H; Ridwan R; Brocke S; Siahaan TJ
Clin Immunol; 2008 Oct; 129(1):69-79. PubMed ID: 18676182
[TBL] [Abstract][Full Text] [Related]
6. Suppression of MOG- and PLP-induced experimental autoimmune encephalomyelitis using a novel multivalent bifunctional peptide inhibitor.
Badawi AH; Siahaan TJ
J Neuroimmunol; 2013 Oct; 263(1-2):20-7. PubMed ID: 23911075
[TBL] [Abstract][Full Text] [Related]
7. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
[TBL] [Abstract][Full Text] [Related]
8. Expansion by self antigen is necessary for the induction of experimental autoimmune encephalomyelitis by T cells primed with a cross-reactive environmental antigen.
Carrizosa AM; Nicholson LB; Farzan M; Southwood S; Sette A; Sobel RA; Kuchroo VK
J Immunol; 1998 Oct; 161(7):3307-14. PubMed ID: 9759846
[TBL] [Abstract][Full Text] [Related]
9. Autopathogenic T helper cell type 1 (Th1) and protective Th2 clones differ in their recognition of the autoantigenic peptide of myelin proteolipid protein.
Das MP; Nicholson LB; Greer JM; Kuchroo VK
J Exp Med; 1997 Sep; 186(6):867-76. PubMed ID: 9294141
[TBL] [Abstract][Full Text] [Related]
10. Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch.
Huan J; Subramanian S; Jones R; Rich C; Link J; Mooney J; Bourdette DN; Vandenbark AA; Burrows GG; Offner H
J Immunol; 2004 Apr; 172(7):4556-66. PubMed ID: 15034073
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of relapsing experimental autoimmune encephalomyelitis in SJL mice by feeding the immunodominant PLP139-151 peptide.
Karpus WJ; Kennedy KJ; Smith WS; Miller SD
J Neurosci Res; 1996 Aug; 45(4):410-23. PubMed ID: 8872901
[TBL] [Abstract][Full Text] [Related]
12. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
Mohindru M; Kang B; Kim BS
J Neuroimmunol; 2004 Oct; 155(1-2):127-35. PubMed ID: 15342203
[TBL] [Abstract][Full Text] [Related]
13. Characterization of proteolipid protein-peptide-specific CD(4)(+) T cell of experimental allergic encephalomyelitis in Biozzi AB/H mice.
Peng Y; Liu CP
Chin Med J (Engl); 2002 Apr; 115(4):521-4. PubMed ID: 12133288
[TBL] [Abstract][Full Text] [Related]
14. Vaccinelike and prophylactic treatments of EAE with novel I-domain antigen conjugates (IDAC): targeting multiple antigenic peptides to APC.
Büyüktimkin B; Manikwar P; Kiptoo PK; Badawi AH; Stewart JM; Siahaan TJ
Mol Pharm; 2013 Jan; 10(1):297-306. PubMed ID: 23148513
[TBL] [Abstract][Full Text] [Related]
15. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
[TBL] [Abstract][Full Text] [Related]
16. Soluble mannosylated myelin peptide inhibits the encephalitogenicity of autoreactive T cells during experimental autoimmune encephalomyelitis.
Kel J; Oldenampsen J; Luca M; Drijfhout JW; Koning F; Nagelkerken L
Am J Pathol; 2007 Jan; 170(1):272-80. PubMed ID: 17200200
[TBL] [Abstract][Full Text] [Related]
17. Encephalitogenicity of murine, but not bovine, DM20 in SJL mice is due to a single amino acid difference in the immunodominant encephalitogenic epitope.
Greer JM; Klinguer C; Trifilieff E; Sobel RA; Lees MB
Neurochem Res; 1997 Apr; 22(4):541-7. PubMed ID: 9130268
[TBL] [Abstract][Full Text] [Related]
18. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
19. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
Young DA; Lowe LD; Booth SS; Whitters MJ; Nicholson L; Kuchroo VK; Collins M
J Immunol; 2000 Apr; 164(7):3563-72. PubMed ID: 10725711
[TBL] [Abstract][Full Text] [Related]
20. Cyclization of PLP
Lourbopoulos A; Matsoukas MT; Katsara M; Deraos G; Giannakopoulou A; Lagoudaki R; Grigoriadis N; Matsoukas J; Apostolopoulos V
Bioorg Med Chem; 2018 May; 26(9):2221-2228. PubMed ID: 29681483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]